v3.20.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 74,511 $ 74,317
Short-term investments 273,201 184,792
Restricted cash - short-term 194 194
Prepaid expenses and other current assets 11,081 13,689
Total current assets 358,987 272,992
Property and equipment, net 53,587 54,176
Operating lease assets 13,321 14,007
Restricted cash - long-term 1,200 1,200
Other assets 1,016 567
Total assets 428,111 342,942
Current liabilities:    
Accounts payable 5,106 7,963
Accrued compensation 12,657 14,706
Accrued research and development expenses 8,244 8,341
Other current liabilities 5,677 5,733
Total current liabilities 31,684 36,743
Operating lease liabilities - long-term 13,420 14,136
Other long-term liabilities 1,882 1,282
Total liabilities 46,986 52,161
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Common stock—$0.0001 par value, 500,000 shares authorized as of June 30, 2020 and December 31, 2019; 74,308 and 56,806 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively 7 6
Additional paid-in capital 1,349,234 1,108,516
Accumulated other comprehensive income 810 220
Accumulated deficit (968,926) (817,961)
Total stockholders’ equity 381,125 290,781
Total liabilities and stockholders’ equity $ 428,111 $ 342,942

Source